// App-Quantinova.ai

Mo1653 : Improvement of Gastrointestinal Symptoms After Gluten-Free Diet in Patients With Irritable Bowel Syndrome Is Dependent on the Presence of Anti-Gliadin Antibodies

Researchers

Presenter

  • Andrea Nardelli

Principal Investigators

  • Justin McCarville

  • Julio C. Bai

  • Elena F. Verdu

  • Premysl Bercik

  • Rajka Borojevic

  • Suzanne Hansen

  • Rashie Brar

  • Yikang Deng

  • Sonia I. Niveloni

  • Edgardo Smecuol

  • David Armstrong

  • Paul Moayyedi

Medical Centers

  • Farncombe Institute, Hamilton, Ontario, Canada

  • Medicine, Mc Master University, Hamilton, Ontario, Canada

  • Hospital de Gastroenterologia Dr. C. B. Udaondo, Buenos Aires, Argentina

Locations

  • Canada

  • Argentina

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Irritable Bowel Syndrome

  • Constipation

  • Depression

  • Anxiety

Biomarkers

  • Cluster of differentiation 79A

  • Tissue transglutaminase

  • HLA-DQ2

Drug/Treatment

  • N/A

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved